Works matching IS 02724391 AND DT 2003 AND VI 59 AND IP 4
1
- Drug Development Research, 2003, v. 59, n. 4, p. 408, doi. 10.1002/ddr.10311
- Anke Rattenholl;
- Martin Steinhoff
- Article
2
- Drug Development Research, 2003, v. 59, n. 4, p. 400, doi. 10.1002/ddr.10310
- Matthias Riewald;
- Wolfram Ruf
- Article
3
- Drug Development Research, 2003, v. 59, n. 4, p. 395, doi. 10.1002/ddr.10309
- Rafael Perini;
- John L. Wallace
- Article
4
- Drug Development Research, 2003, v. 59, n. 4, p. 386, doi. 10.1002/ddr.10308
- Michelle C. Buresi;
- Wallace K. MacNaughton
- Article
5
- Drug Development Research, 2003, v. 59, n. 4, p. 382, doi. 10.1002/ddr.10307
- Article
6
- Drug Development Research, 2003, v. 59, n. 4, p. 375, doi. 10.1002/ddr.10306
- Article
7
- Drug Development Research, 2003, v. 59, n. 4, p. 367, doi. 10.1002/ddr.10305
- Scott R. Macfarlane;
- Robin Plevin
- Article
8
- Drug Development Research, 2003, v. 59, n. 4, p. 355, doi. 10.1002/ddr.10304
- Claudia K. Derian;
- Bruce E. Maryanoff;
- Patricia Andrade-Gordon;
- Han-Cheng Zhang
- Article
9
- Drug Development Research, 2003, v. 59, n. 4, p. 350, doi. 10.1002/ddr.10303
- Article
10
- Drug Development Research, 2003, v. 59, n. 4, p. 344, doi. 10.1002/ddr.10302
- Morley D. Hollenberg;
- Steven J. Compton
- Article
11
- Drug Development Research, 2003, v. 59, n. 4, p. 336, doi. 10.1002/ddr.10301
- Article
12
- Drug Development Research, 2003, v. 59, n. 4, p. 334, doi. 10.1002/ddr.10300
- Article
13
- Drug Development Research, 2003, v. 59, n. 4, p. 333, doi. 10.1002/ddr.10299
- Article